Solvotrin Therapeutics is a pharmaceutical company that focuses on improving and enhancing existing medications. Founded by Pat O’Flynn in 2009, Solvotrin Therapeutics is backed by investors that include Enterprise Ireland, Elkstone Capital Partners, Elkstone, RAB Capital, and Kevin Fielding and is headquartered in Cork.
FOUNDED:
2009
INDUSTRY:
Chemical, Medical, Pharmaceutical
FOUNDERS:
Pat O'Flynn
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
